A detailed history of Klcm Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Klcm Advisors, Inc. holds 9,915 shares of ABT stock, worth $1.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,915
Previous 9,995 0.8%
Holding current value
$1.03 Million
Previous $1.1 Million 2.36%
% of portfolio
0.15%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

SELL
$109.52 - $120.96 $8,761 - $9,676
-80 Reduced 0.8%
9,915 $1.13 Million
Q4 2023

Jan 30, 2024

SELL
$90.19 - $110.4 $42,930 - $52,550
-476 Reduced 4.55%
9,995 $1.1 Million
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $6,018 - $7,221
-63 Reduced 0.6%
10,471 $1.01 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $98,462 - $109,707
977 Added 10.22%
10,534 $1.15 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $1,743 - $2,052
18 Added 0.19%
9,557 $967,000
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $4,467 - $5,241
-47 Reduced 0.49%
9,539 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $52,830 - $61,168
546 Added 6.04%
9,586 $927,000
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $10,615 - $12,830
104 Added 1.16%
9,040 $982,000
Q1 2022

May 03, 2022

SELL
$114.02 - $139.04 $6,499 - $7,925
-57 Reduced 0.63%
8,936 $1.06 Million
Q4 2021

Jan 31, 2022

SELL
$115.53 - $141.46 $45,056 - $55,169
-390 Reduced 4.16%
8,993 $1.27 Million
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $116 - $129
1 Added 0.01%
9,383 $1.11 Million
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $26,130 - $30,758
247 Added 2.7%
9,382 $1.09 Million
Q1 2021

Apr 21, 2021

SELL
$108.84 - $128.23 $22,965 - $27,056
-211 Reduced 2.26%
9,135 $1.1 Million
Q3 2020

Nov 03, 2020

SELL
$91.64 - $111.29 $13,746 - $16,693
-150 Reduced 1.58%
9,346 $1.02 Million
Q2 2020

Jul 27, 2020

BUY
$76.57 - $98.0 $7,580 - $9,702
99 Added 1.05%
9,496 $868,000
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $6,282 - $9,186
100 Added 1.08%
9,397 $741,000
Q4 2019

Feb 04, 2020

SELL
$78.51 - $87.4 $49,382 - $54,974
-629 Reduced 6.34%
9,297 $808,000
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $13,176 - $14,287
161 Added 1.65%
9,926 $830,000
Q3 2019

Nov 04, 2019

BUY
$81.84 - $88.74 $25,124 - $27,243
307 Added 3.25%
9,765 $817,000
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $4,445 - $5,185
61 Added 0.65%
9,458 $795,000
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $75,888 - $91,748
1,146 Added 13.89%
9,397 $751,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $12,325 - $13,962
188 Added 2.33%
8,251 $597,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $105,748 - $127,573
-1,739 Reduced 17.74%
8,063 $591,000
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $22,912 - $25,288
-398 Reduced 3.9%
9,802 $598,000
Q1 2018

May 10, 2018

SELL
$56.27 - $63.62 $259,292 - $293,160
-4,608 Reduced 31.12%
10,200 $611,000
Q4 2017

Feb 15, 2018

BUY
$53.68 - $57.47 $15,513 - $16,608
289 Added 1.99%
14,808 $845,000
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $105,395 - $117,632
-2,193 Reduced 13.12%
14,519 $775,000
Q2 2017

Aug 15, 2017

BUY
N/A
16,712
16,712 $812,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Klcm Advisors, Inc. Portfolio

Follow Klcm Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.